Investigation of aberrant translational control of c-myc in cell lines derived from patients with multiple myeloma

Current Topics in Microbiology and Immunology

Volumn 224, Issue , 1997, Pages 269-278

  Willis, A E ^a   Paulin, F E M ^a   West, M J ^a   Whitney, R L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN;

CONFERENCE PAPER; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; ONCOGENE C MYC; POLYSOME; PRIORITY JOURNAL; PROTEIN RNA BINDING; SEQUENCE ANALYSIS; SPECIES DIFFERENTIATION;

EID: 0030793834     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-60801-8_28     Document Type: Conference Paper

References (20)

1. Barker HF, Hamilton MS, Ball J, Drew M and Franklin IM. (1992). Mutiple myeloma: The biology of the malignant plasma cell. British Journal Of Haematology., 81: 331-335.
2. Caligaris-Cappio M, Gaidano M, Gaboli M, Schena AS, and Marchisio C. (1991) The role of bone marrow stromal cells in the growth of human mutiple myeloma. Blood:77 2688-2693
3. Carter A, Merchav I, Silvian-Draxler I and Tatarsky I. (1990) The role of inerleukin-1 and tumour necrosis factor alpha in human multiple myeloma. Blood 74:424-431.
4. Corradini P., Ladetto M, Voena C, Paulumbo A, Inghirami G, Knowles DM, Boccadoro M and Pilleri A., (1993) Mutational Activation of N- and K-ras Oncogenes in Plasma Cell Dyscrasias. Blood 81: 2708-2713.
5. Darveau A, Pelletier J and Sonenberg N. (1985) Differenital efficiences of in vitro translation of mouse c-myc transcripts differing in the 5′ untranslated region. Proc.Natl.Acad. Sci..USA., 82:2315-2319
6. Gazin C, Dupont de Dinechin S, Hampe A, Masson J-M, Martin P, Stehelin D and Galibert F. (1984). Nucleotide sequence of the human c-myc locis:provocative open reading frame within the first exon. EMBO. J., 3:383-387.
7. Gray N and Hentze M. (1994). Regulation of protein synthesis by mRNA structure. Molecular Biology Reports, 19: 195-200.
8. Hann SR and Eisenman RN. (1984). Proteins expressed by the c-myc oncogene in lymphomas of human and avian origin. Mol.Cell Biol., 4: 11. 2486-2497.
9. Hiltzer J, Martinez-Valdez D, Berghasel M, Minden M and Messener H., (1991) Role of Interleukin-6 in the proliferation of human multiple myeloma cell lines oci-my 1 to 7 established from patients with advanced Stage of the disease. Blood 8:1996-2004.
10. Hollis GF, Gazdar AF, Bertness V and Kirsch IR. (1988). Complex transnational disrupts c-myc regulation in a human plasma cell myeloma. Mol. Cell. Biol., 8: 124-129.
11. Hershey JWB (1991). Translational control in mammalian cells. Annu. Rev. Biochem., 60:717-755.
12. Lewis J and MacKenzie M (1984). Non-random chromosomal aberrations associated with multiple myeloma. Haematology Oncol., 2 :307-317.
13. Neivizky R, Siegel D and Michaeli J. (1993). Biology and treatment of multiple myeloma. Blood, 7: 24-33
14. Neri A, Murphy JP, Gro L, Ferrero D, Tarella C, Baldini L and Dalla-Favera R. (1989). RAS Oncogene mutations in multiple myeloma J. Exp. Med., 170: 1715-1722.
15. Neri A, Baldini L, Trecca D, Gro L, Polli E and Maiolo AT. (1993). p53 Gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood, 81: 128-135.
16. Portier M, Moles JP, Mazars G, Jeanteur P, Bataille R and Theillet C. (1992). p53 and RAS gene mutations in multiple myeloma. Oncogene, 7: 2539-2543.
17. Parkin N, Darveau A, Nicholson R and Sonenberg N. (1988). cis-acting translational affects of the 5′ non-coding region of the c-myc mRNA Mol.Cell.Biol., 8: 2875-2883.
18. Selvanayagam PM, Blick F, Narni P, van Tuinen DH, Ledbetter R, Alexanian GF, Saunders G and Barlogie B. (1988). Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. Blood, 71, 30-35.
19. Sullivan NF, Willis AE, Moore JP and Lindahl T. (1989). High levels of the c-myc protein in cell lines of Bloom's syndrome origin. Oncogene 4: 1509-1511.
20. Theodorakis NG, Banerji SS and Morimoto RI. (1988). HSP70 mRNA Translation in chicken reticulocytes is regulated at the level of elongation. J. Biol. Chem., 263 :14579-14585.